Add Company
Join Now

Granza Bio (YC W24) Revenue and Competitors

License our Company Data API

USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Granza Bio (YC W24)'s estimated annual revenue is currently $1.1M per year.(i)
  • Granza Bio (YC W24)'s estimated revenue per employee is $155,000

Employee Data

  • Granza Bio (YC W24) has 7 Employees.(i)
  • Granza Bio (YC W24) grew their employee count by 75% last year.

Granza Bio (YC W24)'s People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Founder - Granza BioReveal Email/Phone
3
Head Research And DevelopmentReveal Email/Phone
4
Research ScientistReveal Email/Phone
5
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$9.1M59-9%N/AN/A
#10
$16.6M1073%N/AN/A
Add Company

What Is Granza Bio (YC W24)?

Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues. For their lead candidate, Granza Bio is leveraging the discovery of the immune system’s powerful suite of weapons, “attack particles”. Utilizing their advanced delivery platform, they aim to target these \attack particles\ against a range of diseases such as cancer, autoimmune disorders, and infections. Interested to know more?

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M70%$6.1M
#2
$3.5M7-30%N/A
#3
$0.5M7N/AN/A
#4
$0.9M7N/AN/A
#5
$0.5M7N/AN/A